282 related articles for article (PubMed ID: 11303595)
1. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.
Hoque A; Lippman SM; Boiko IV; Atkinson EN; Sneige N; Sahin A; Weber DM; Risin S; Lagios MD; Schwarting R; Colburn WJ; Dhingra K; Follen M; Kelloff GJ; Boone CW; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):249-59. PubMed ID: 11303595
[TBL] [Abstract][Full Text] [Related]
2. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
3. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
5. Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast.
Tan PH; Goh BB; Chiang G; Bay BH
Mod Pathol; 2001 Oct; 14(10):937-41. PubMed ID: 11598161
[TBL] [Abstract][Full Text] [Related]
6. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.
Provenzano E; Hopper JL; Giles GG; Marr G; Venter DJ; Armes JE
Pathology; 2004 Jun; 36(3):221-9. PubMed ID: 15203725
[TBL] [Abstract][Full Text] [Related]
7. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
[TBL] [Abstract][Full Text] [Related]
9. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.
Hird RB; Chang A; Cimmino V; Diehl K; Sabel M; Kleer C; Helvie M; Schott A; Young J; Hayes D; Newman L
Cancer; 2006 May; 106(10):2113-8. PubMed ID: 16596655
[TBL] [Abstract][Full Text] [Related]
10. Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
Hoque A; Sneige N; Sahin AA; Menter DG; Bacus JW; Hortobagyi GN; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):587-90. PubMed ID: 12050101
[TBL] [Abstract][Full Text] [Related]
11. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
[TBL] [Abstract][Full Text] [Related]
14. [Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?].
André G; Tunon-de-Lara C; Macgrogan G; Laharie-Mineur H; Bussieres JE; Valentin F; Barreau B; Dilhuydy MH; Dilhuydy JM; Mauriac L; Debled M; Durand M; Mathoulin S; Avril A
J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):260-6. PubMed ID: 17376610
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrence after ductal carcinoma in situ of the breast.
Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
[TBL] [Abstract][Full Text] [Related]
16. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
17. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
[TBL] [Abstract][Full Text] [Related]
19. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
MacDonald HR; Silverstein MJ; Mabry H; Moorthy B; Ye W; Epstein MS; Holmes D; Silberman H; Lagios M
Am J Surg; 2005 Oct; 190(4):521-5. PubMed ID: 16164913
[TBL] [Abstract][Full Text] [Related]
20. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
